China SXT Pharmaceuticals, Inc., a pharmaceutical company, is engaged in the research, development, manufacture, marketing and sale of Traditional Chinese Medicine Tablets (TCMP) in China. The company is headquartered in Taizhou, China.
| Revenue (TTM) | $1.14M |
| Gross Profit (TTM) | 248,700 |
| EBITDA | $-7.05M |
| Operating Margin | -153.30% |
| Return on Equity | -27.50% |
| Return on Assets | -15.80% |
| Revenue/Share (TTM) | $1.67 |
| Book Value | $26.16 |
| Price-to-Book | 3.15 |
| Price-to-Sales (TTM) | 69.64 |
| EV/Revenue | 58.5 |
| EV/EBITDA | 29.56 |
| Quarterly Earnings Growth (YoY) | 42.60% |
| Quarterly Revenue Growth (YoY) | -43.90% |
| Shares Outstanding | $32.22M |
| Float | 560,980 |
| % Insiders | 0.00% |
| % Institutions | 0.24% |
Volatility is currently expanding